Publikációk

Protein kinase inhibitor-induced endothelial cell cytotoxicity and its prediction based on calculated molecular descriptors.
Herczenik E, Varga Z, Eros D, Makó V, Oroszlán M, Rugonfalvi-Kiss S, Romics L, Füst G, Kéri G, Orfi L, Cervenak L.
J Recept Signal Transduct Res. 2009;29(2):75-83. doi: 10.1080/10799890902857976.

A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern.
Hosszúfalusi N, Karcagi V, Horváth R, Palik E, Várkonyi J, Rajczy K, Prohászka Z, Szentirmai C, Karádi I, Romics L, Pánczél P.
Diabetes Metab Res Rev. 2009 Feb;25(2):127-35. doi: 10.1002/dmrr.841.

["Without empathy one cannot be a good physician!" Interview with dr. László Romics].
Romics L.
Orv Hetil. 2008 Mar 16;149(11):527. doi: 10.1556/OH.2008.11I. Hungarian. No abstract available.

Early rise in serum VEGF and PDGF levels predisposes patients with a normal MBL2 genotype to restenosis after eversion endarterectomy.
Szabó A, Laki J, Madsen HO, Dósa E, Prohászka Z, Rugonfalvi-Kiss S, Kókai M, Acsádi G, Karádi I, Entz L, Selmeci L, Romics L, Füst G, Garred P, Cervenak L.
Stroke. 2007 Aug;38(8):2247-53. Epub 2007 Jul 12.

Factor V Leiden and apolipoprotein E genotypes in severe femoropopliteal atherosclerosis with restenosis.
Vallus G, Dlustus B, Acsády G, Papp Z, Skopál J, Nagy Z, Prohászka Z, Romics L, Karádi I, Nagy B.
Clin Chim Acta. 2007 Feb;377(1-2):256-60. Epub 2006 Oct 13.

Novel anti-cholesterol monoclonal immunoglobulin G antibodies as probes and potential modulators of membrane raft-dependent immune functions.
Bíró A, Cervenak L, Balogh A, Lorincz A, Uray K, Horváth A, Romics L, Matkó J, Füst G, László G.
J Lipid Res. 2007 Jan;48(1):19-29. Epub 2006 Oct 5.

Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP.
Oroszlán M, Herczenik E, Rugonfalvi-Kiss S, Roos A, Nauta AJ, Daha MR, Gombos I, Karádi I,Romics L, Prohászka Z, Füst G, Cervenak L.
Int Immunol. 2006 Jun;18(6):871-8. Epub 2006 Apr 24.

Dramatic changes in the serum levels of anti-cholesterol antibodies after eversion endarterectomy in patients with severe carotid atherosclerosis.
Bíró A, Dósa E, Horváth A, Prohászka Z, Rugonfalvi-Kiss S, Szabó A, Karádi I, Acsády G, Selmeczi L, Entz L, Füst G, Romics L.
Immunol Lett. 2005 Jun 15;99(1):51-6. Epub 2005 Jan 19.

Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.
Széplaki G, Varga L, Valentin S, Kleiber M, Karádi I, Romics L, Füst G, Farkas H.
J Allergy Clin Immunol. 2005 Apr;115(4):864-9.

High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype.
Rugonfalvi-Kiss S, Dósa E, Madsen HO, Endrész V, Prohászka Z, Laki J, Karádi I, Gönczöl E, Selmeci L, Romics L, Füst G, Entz L, Garred P.
Stroke. 2005 May;36(5):944-8. Epub 2005 Mar 24.

Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy.
Dósa E, Rugonfalvi-Kiss S, Prohászka Z, Szabó A, Karádi I, Selmeci L, Romics L, Füst G, Acsády G, Entz L.
Inflamm Res. 2004 Nov;53(11):631-5.

High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease.
Jánoskuti L, Förhécz Z, Hosszúfalusi N, Kleiber M, Walentin S, Bálint O, Duba J, Rugonfalvi-Kiss S,Romics L, Karádi I, Füst G, Prohászka Z.
Eur J Clin Invest. 2005 Feb;35(2):104-11.

Low levels of antibodies against E. coli and mycobacterial 65kDa heat shock proteins in patients with inflammatory bowel disease.
Huszti Z, Bene L, Kovács A, Fekete B, Füst G, Romics L, Singh M, Prohászka Z.
Inflamm Res. 2004 Oct;53(10):551-5.

Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women.
Széplaki G, Prohászka Z, Duba J, Rugonfalvi-Kiss S, Karádi I, Kókai M, Kramer J, Füst G, Kleiber M,Romics L, Varga L.
Atherosclerosis. 2004 Dec;177(2):383-9.

Genetic basis of tobacco smoking: strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior.
Füst G, Arason GJ, Kramer J, Szalai C, Duba J, Yang Y, Chung EK, Zhou B, Blanchong CA, Lokki ML, Bödvarsson S, Prohászka Z, Karádi I, Vatay A, Kovács M, Romics L, Thorgeirsson G, Yu CY.
Int Immunol. 2004 Oct;16(10):1507-14. Epub 2004 Aug 31.

Search for factor V Arg306 Cambridge and Hong Kong mutations in mixed Hungarian population samples.
Komlósi K, Havasi V, Bene J, Ghosh M, Szolnoki Z, Melegh G, Nagy A, Stankovics J, Császár A, Papp E, Gasztonyi B, Tóth K, Mózsik G, Romics L, ten Cate H, Smits P, Méhes K, Kosztolányi G, Melegh B.
Acta Haematol. 2003;110(4):220-2. No abstract available.

Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene.
Fülöp AK, Földes A, Buzás E, Hegyi K, Miklós IH, Romics L, Kleiber M, Nagy A, Falus A, Kovács KJ.
Endocrinology. 2003 Oct;144(10):4306-14. Epub 2003 Jun 26.

Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms.
Reiber I, Mezo I, Kalina A, Pálos G, Romics L, Császár A.
J Nutr Biochem. 2003 Jul;14(7):394-400.

Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.
Vatay A, Bene L, Kovács A, Prohászka Z, Szalai C, Romics L, Fekete B, Karádi I, Füst G.
Immunogenetics. 2003 Jul;55(4):247-52. Epub 2003 Jun 14.

Serum anti-cholesterol antibodies in chronic hepatitis-C patients during IFN-alpha-2b treatment.
Biró A, Horváth A, Varga L, Nemesánszky E, Csepregi A, Dávid K, Tolvaj G, Ibrányi E, Telegdy L, Pár A, Romics L, Karádi I, Horányi M, Gervain J, Ribiczey P, Csöndes M, Füst G.
Immunobiology. 2003;207(3):161-8.

[Antilipemic therapy and rhabdomyolysis].
Paragh G, Balogh Z, Romics L.
Orv Hetil. 2003 Mar 16;144(11):515-20. Review. Hungarian.

Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations.
Vatay A, Yang Y, Chung EK, Zhou Bi, Blanchong CA, Kovács M, Karádi I, Füst G, Romics L L, Varga L, Yu CY, Szalai C.
Hum Immunol. 2003 May;64(5):543-52.

Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression.
Hosszúfalusi N, Vatay A, Rajczy K, Prohászka Z, Pozsonyi E, Horváth L, Grosz A, Gero L, Madácsy L,Romics L, Karádi I, Füst G, Pánczél P.
Diabetes Care. 2003 Feb;26(2):452-7.

[Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes].
Dura E, Mészáros Z, Salacz G, Magyar K, Romics L, Karádi I.
Orv Hetil. 2002 Nov 24;143(47):2637-44. Hungarian.

Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.
Veres A, Füst G, Smieja M, McQueen M, Horváth A, Yi Q, Bíró A, Pogue J, Romics L, Karádi I, Singh M, Gnarpe J, Prohászka Z, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Study Investigators.
Circulation. 2002 Nov 26;106(22):2775-80.

Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin.
Rugonfalvi-Kiss S, Endrész V, Madsen HO, Burián K, Duba J, Prohászka Z, Karádi I, Romics L, Gönczöl E, Füst G, Garred P.
Circulation. 2002 Aug 27;106(9):1071-6.

Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60.
Kalabay L, Fekete B, Czirják L, Horváth L, Daha MR, Veres A, Fónyad G, Horváth A, Viczián A, Singh M, Hoffer I, Füst G, Romics L, Prohászka Z.
Helicobacter. 2002 Aug;7(4):250-6.

IL-6 and lipoprotein(a) [LP(a)] concentrations are related only in patients with high APO(a) isoforms in monoclonal gammopathy.
Horváth L, Császár A, Falus A, Dieplinger H, Horváth A, Puskás E, Halm G, Bányai A, Pálóczi K, László E, Kalabay L, Romics L, Füst G.
Cytokine. 2002 Jun 21;18(6):340-3.

Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease.
Bene L, Füst G, Huszti Z, Hernádi Z, Fekete B, Mészáros M, Veres A, Kovács A, Miklós K, Singh M,Romics L, Prohászka Z.
Dig Dis Sci. 2002 Jul;47(7):1432-7.

Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis.
Karádi I, Mészáros Z, Csányi A, Szombathy T, Hosszúfalusi N, Romics L, Magyar K.
Clin Chim Acta. 2002 Sep;323(1-2):139-46.

Complement activating antibodies against the human 60 kDa heat shock protein as a new independent family risk factor of coronary heart disease.
Veres A, Szamosi T, Ablonczy M, Szamosi T Jr, Singh M, Karádi I, Romics L, Füst G, Prohászka Z.
Eur J Clin Invest. 2002 Jun;32(6):405-10.

Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived myocardial infarction.
Császár A, Duba J, Melegh B, Kramer J, Szalai C, Prohászka Z, Karádi I, Kovács M, Méhes K,Romics L, Füst G.
Exp Clin Immunogenet. 2001;18(4):206-12.

Association of polymorphisms and allelic combinations in the tumour necrosis factor-alpha-complement MHC region with coronary artery disease.
Szalai C, Füst G, Duba J, Kramer J, Romics L, Prohászka Z, Császár A.
J Med Genet. 2002 Jan;39(1):46-51. No abstract available.

Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus.
Horváth L, Cervenak L, Oroszlán M, Prohászka Z, Uray K, Hudecz F, Baranyi E, Madácsy L, Singh M,Romics L, Füst G, Pánczél P.
Immunol Lett. 2002 Mar 1;80(3):155-62.

High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients.
Horváth L, Czirják L, Fekete B, Jakab L, Pozsonyi T, Kalabay L, Romics L, Miklós K, Varga L, Prohászka Z, Szakács A, Nagy E, Daha MR, Füst G.
Clin Exp Rheumatol. 2001 Nov-Dec;19(6):667-72.

[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L.
Orv Hetil. 2001 Nov 18;142(46):2571-8. Hungarian.

High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART.
Horváth A, Bánhegyi D, Bíró A, Ujhelyi E, Veres A, Horváth L, Prohászka Z, Bácsi A, Tarján V, Romics L, Horváth I, Tóth FD, Füst G, Karádi I.
Immunobiology. 2001 Aug;203(5):756-68.

Anticholesterol antibody levels in patients with systemic lupus erythematosus.
Nagy G, Horváth A, Füst G, Romics L, Gergely P, Karádi I.
Ann Rheum Dis. 2001 Jul;60(7):722-3. No abstract available.

Anti-cholesterol antibodies (ACHA) in patients with different atherosclerotic vascular diseases and healthy individuals. Characterization of human ACHA.
Horváth A, Füst G, Horváth I, Vallus G, Duba J, Harcos P, Prohászka Z, Rajnavölgyi E, Jánoskuti L, Kovács M, Császár A, Romics L, Karádi I.
Atherosclerosis. 2001 May;156(1):185-92.

[Medical education and the needs of human resources in the Hungarian health care system].
Szócska G, Romics L.
Orv Hetil. 2001 Apr 1;142(13):659-64. Hungarian.

Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects.
Prohászka Z, Duba J, Horváth L, Császár A, Karádi I, Szebeni A, Singh M, Fekete B, Romics L, Füst G.
Eur J Clin Invest. 2001 Apr;31(4):285-92.

Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis.
Burian K, Kis Z, Virok D, Endresz V, Prohaszka Z, Duba J, Berencsi K, Boda K, Horvath L, Romics L, Fust G, Gonczol E.
Circulation. 2001 Mar 20;103(11):1503-8.

Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases.
Horváth L, Czirják L, Fekete B, Jakab L, Prohászka Z, Cervenak L, Romics L, Singh M, Daha MR, Füst G.
Immunol Lett. 2001 Jan 1;75(2):103-9.

Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary.
Kalina A, Császár A, Czeizel AE, Romics L, Szabóki F, Szalai C, Reiber I, Németh A, Stephenson S, Williams RR.
Atherosclerosis. 2001 Jan;154(1):247-51.

Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases.
Kramer J, Harcos P, Prohászka Z, Horváth L, Karádi I, Singh M, Császár A, Romics L, Füst G.
Stroke. 2000 Nov;31(11):2648-52.

Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis.
Mészáros Z, Karádi I, Csányi A, Szombathy T, Romics L, Magyar K.
Eur J Drug Metab Pharmacokinet. 1999 Oct-Dec;24(4):299-302.

Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population.
Halmos B, Szalay F, Cserniczky T, Nemesanszky E, Lakatos P, Barlage S, Schmitz G, Romics L, Csaszar A.
Dig Dis Sci. 2000 Jun;45(6):1091-5.

[Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P, Külkey O, Luczay A, Bornemisza B, Illyés G, Halmos T, Baranyi E, Blatniczky L, Mészáros J, Kerényi Z, Geró L, Tamás G, Hosszúfalusi N, Horváth L, Madácsy L, Romics L.
Orv Hetil. 1999 Nov 28;140(48):2695-701. Hungarian.

Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome.
Szombathy T, Jánoskúti L, Szalai C, Császár A, Miklósi M, Mészáros Z, Kempler P, László Z, Fenyvesi T, Romics L.
Am Heart J. 2000 Jan;139(1 Pt 1):101-5.

Distribution of apolipoprotein(a) isoforms in normotensive and severe preeclamptic women.
Nagy B, Rigó J Jr, Fintor L, Romics L, Papp Z, Karádi I.
J Matern Fetal Med. 1999 Nov-Dec;8(6):270-4.

Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability.
Prohászka Z, Duba J, Lakos G, Kiss E, Varga L, Jánoskuti L, Császár A, Karádi I, Nagy K, Singh M,Romics L, Füst G.
Int Immunol. 1999 Sep;11(9):1363-70.

Apolipoprotein E gene polymorphism frequencies in a sample of healthy Hungarians.
Nagy B, Karádi I, Fintor L, Rigó J Jr, Romics L, Papp Z.
Clin Chim Acta. 1999 Apr;282(1-2):147-50.

Genetic investigation of patients with hypercholesterolemia type IIa.
Szalai C, Császár A, Czinner A, Palicz T, Halmos B, Romics L.
Clin Genet. 1999 Jan;55(1):67-8. No abstract available.

Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride.
Mészáros Z, Szombathy T, Raimondi L, Karádi I, Romics L, Magyar K.
Metabolism. 1999 Jan;48(1):113-7.

Aspirin in the management of recurrent herpes simplex virus infection.
Karádi I, Kárpáti S, Romics L.
Ann Intern Med. 1998 Apr 15;128(8):696-7. No abstract available.

Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women.
Nagy B, Tóth T, Rigó J Jr, Karádi I, Romics L, Papp Z.
Clin Genet. 1998 Jun;53(6):478-81.

[Incidence of familial defective apolipoprotein B-100 in cases of patients diagnosed with familial hypercholesterolemia].
Kalina A, Czeizel E, Romics L, Pados G, Reiber I, Dósa A, Hermányi I, Lakatos Z, Tarján J, Kollega-Tarsoly E, Kovács M, Szalai C, Császár A.
Orv Hetil. 1998 Mar 29;139(13):755-9. Review. Hungarian.

Association of angiotensin II type 1 receptor polymorphism with resistant essential hypertension.
Szombathy T, Szalai C, Katalin B, Palicz T, Romics L, Császár A.
Clin Chim Acta. 1998 Jan 12;269(1):91-100.

Apolipoprotein A-IV and E polymorphisms in children with IDDM.
Szalai C, Császár A, Czinner A, Bihari-Varga M, Romics L.
Diabetes Care. 1997 Dec;20(12):1926-7. No abstract available.

Intimal-medical thickness of the carotid artery in NIDDM patients.
Winkler G, Salamon F, Porochnavec M, Solymosi D, Demeter J, Simon K, Salamon D, Karádi I, Cseh K, Romics L.
Diabetes Care. 1997 Dec;20(12):1923-4. No abstract available.

Interpopulation effect of ACE I/D polymorphism on serum concentration of ACE in diagnosis of sarcoidosis.
Császár A, Halmos B, Palicz T, Szalai C, Romics L.
Lancet. 1997 Aug 16;350(9076):518. No abstract available.

Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease.
Császár A, Kálmán J, Szalai C, Janka Z, Romics L.
Neurosci Lett. 1997 Jul 25;230(3):151-4.

Decreased serum alfa2-HS-glycoprotein concentration in patients with primary biliary cirrhosis.
Kalabay L, Szalay F, Nemesánszky E, Telegdy L, Jakab L, Romics L.
J Hepatol. 1997 Jun;26(6):1426-7. No abstract available.

[Study of low density lipoprotein (LDL) receptor mutations, using restriction endonucleases, in familial hypercholesterolemia].
Kerepesi M, Császár A, Földi J, Mesterházy J, Romics L.
Orv Hetil. 1997 Jan 5;138(1):15-8. Review. Hungarian.

Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis.
Romics L, Nemesánszky E, Szalay F, Császár A, Tresch J, Karádi I.
Clin Chim Acta. 1996 Nov 29;255(2):165-71.

[Effect of pancreas transplantation on triglyceride metabolism].
Pálos G, Domán J, Föger B, Karádi I, Romics L.
Orv Hetil. 1995 Nov 26;136(48):2609-14. Hungarian.

[Molecular genetic markers of Alzheimer dementia].
Németh A, Urbanics K, Tariska P, Kramer J, Füst G, Dinya E, Abel T, Romics L, Pados G, Manfred H, et al.
Orv Hetil. 1995 Sep 3;136(36):1931-5. Review. Hungarian.

High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism.
Császár A, Karádi I, Juhász E, Romics L.
Eur J Clin Invest. 1995 May;25(5):368-70.

Microangiopathy in primary hyperlipoproteinemia.
Romics L, Neumark T.
Acta Biomed Ateneo Parmense. 1995;66(3-4):185-8.

[Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
Romics L, Karádi I, Csanády M, Gógl A, Jánosi A, Ofner P, Tarján J, Varga L, Wórum F, Zeltner G.
Orv Hetil. 1994 Oct 2;135(40):2187-91. Hungarian.

[Management of arteriosclerosis-related lipid metabolism disorders. Recommendations of the Hungarian Lipid Consensus Conference].
Romics L, Szollár L, Zajkás G.
Orv Hetil. 1993 Jan 31;134(5):227-38. Review. Hungarian. No abstract available.

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus.
Császár A, Dieplinger H, Sandholzer C, Karádi I, Juhász E, Drexel H, Halmos T, Romics L, Patsch JR, Utermann G.
Diabetologia. 1993 Jan;36(1):47-51.

[The effect of low density lipoprotein (LDL) on NO formation and on arginase activity in mouse peritoneal macrophages].
Romics L, Hesz A, Csuka I, Antoni F, Karádi I.
Orv Hetil. 1992 May 31;133(22):1359-62. Review. Hungarian.

[Relationship between platelet hyperactivation and dyslipoproteinemia in diabetic nephropathy].
Tóth L, Szénási P, Varsányi-Nagy M, Szilvási I, Vörös P, Romics L, Kammerer L.
Orv Hetil. 1992 Apr 26;133(17):1037-40. Review. Hungarian.

[The role of endogenous free radicals of nitric oxide (NO)].
Antoni F, Csuka I, Romics L.
Orv Hetil. 1992 Mar 29;133(13):773-6. Review. Hungarian.

Platelet function in male diabetics with and without macrovascular complications.
Tóth L, Szénási P, Jámbor G, Kammerer L, Romics L.
Diabetes Res Clin Pract. 1992 Feb;15(2):143-8.

[Results of cholesterol screening in Budapest].
Czeizel E, Romics L, Pados G.
Orv Hetil. 1992 Jan 26;133(4):254-5. Hungarian. No abstract available.

Elevated levels of plasma and urine beta-thromboglobulin or thromboxane-B2 as markers of real platelet hyperactivation in diabetic nephropathy.
Tóth L, Szénási P, Varsányi MN, Szilvási I, Lehoczky E, Kammerer L, Romics L.
Haemostasis. 1992;22(6):334-9. Erratum in: Haemostasis 1993 Mar-Apr;23(2):103.

The effect of azathioprine, cyclosporine A and insulin on the in vitro lymphocyte-mediated cytotoxicity in type I diabetic patients.
Horváth M, Varsányi M, Bándi E, Balázsi I, Romics L.
Exp Clin Endocrinol. 1992;100(3):90-4.

[In memory of Prof. Ferenc Gráf].
Romics L.
Orv Hetil. 1991 Oct 6;132(40):2213-4. Hungarian. No abstract available.

[Distribution of apolipoprotein A I and B in the blood according to age and gender, as well as their relation to blood cholesterol levels in the Hungarian blood donor population].
Császár A, Romics L, Karádi I, Tresch J, Hans-Jürgen M.
Orv Hetil. 1991 Aug 18;132(33):1795-800. Review. Hungarian.

[Plasma and urine beta-thromboglobulin determination in the detection of thrombocyte hyperactivation in diabetic nephropathies].
Tóth L, Szénási P, Varsányi-Nagy M, Szilvási I, Lehoczky E, Németh C, Kammerer L, Romics L.
Orv Hetil. 1991 May 26;132(21):1135-8, 1141. Review. Hungarian.

Platelet membrane fluidity in type IIA, type IIB and type IV hyperlipoproteinemia.
Malle E, Sattler W, Prenner E, Leis HJ, Karadi I, Knipping G, Romics L, Kostner GM.
Atherosclerosis. 1991 Apr;87(2-3):159-67.

[Plasma concentration of lipoprotein(a) and distribution of its subtypes in the healthy population of Hungary].
Császár A, Romics L, Lackner C, Dieplinger H, Karádi I, Utermann G.
Orv Hetil. 1990 Sep 23;131(38):2071-5. Review. Hungarian.

Physiological and clinical importance of lipoprotein(a).
Romics L, Karádi I, Császár A, Kostner GM.
Tokai J Exp Clin Med. 1990 May;15(2-3):149-54. Review.

[Necrobiosis lipoidica].
Daróczy J, Császár A, Hosszúfalusi N, Romics L.
Morphol Igazsagugyi Orv Sz. 1990 Apr;30(2):90-5. Hungarian.

The effect of Etofibrate (Lipo-Merz) on "in vitro" cellular immune response and on lipid parameters of men with myocardial infarction and with arteriosclerosis obliterans.
Horváth M, Varsányl M, Jovanovich N, Romics L, Gerö S.
Allergol Immunopathol (Madr). 1990 Mar-Apr;18(2):95-9.

[Correlation of thrombocyte reactivity and serum levels of HbA1c, cholesterol and creatinine in diabetes mellitus].
Tóth L, Szénási P, Kammerer L, Romics L.
Orv Hetil. 1990 Feb 25;131(8):405-6, 409-10. Review. Hungarian.

Long lasting efficacy of Bezalip retard on the regulation of lipid levels after discontinuation of administration in patients with hyperlipoproteinemia.
Császár A, Karádi I, Köszegi G, Pados G, Németh-Csóka M, Pichler M, Romics L.
Klin Wochenschr. 1990;68 Suppl 22:96-8. No abstract available.

Presynaptic effect of dexmedetomidine on cholinergic chemical transmission.
Tarkovács G, Rakovska A, Romics L, Vizi ES.
Acta Physiol Hung. 1990;75 Suppl:275-6. No abstract available.

[Necrobiosis lipoidica without diabetes mellitus (diagnostic and therapeutic possibilities)].
Császár A, Daróczy J, Szénási P, Anda L, Tóth L, Hosszúfalusi N, Karádi I, Kalabay L, Romics L.
Orv Hetil. 1989 Oct 1;130(40):2141-5. Review. Hungarian.

Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin.
Karádi I, Romics L, Pálos G, Domán J, Kaszás I, Hesz A, Kostner GM.
Clin Chem. 1989 Oct;35(10):2121-3.

[Distribution of lipoprotein fractions in men with arteriosclerosis obliterans].
Karádi I, Szabolcs Z, Szénási P, Hosszúfalusi N, Császár A, Kusztos R, Romics L.
Orv Hetil. 1989 Jul 9;130(28):1489-92. Hungarian.

Binding of fibronectin to human lipoproteins.
Cseh K, Karadi I, Rischak K, Szollar L, Janoki G, Jakab L, Romics L.
Clin Chim Acta. 1989 Jun 15;182(1):75-85.

[Differences in platelet aggregation in various microangiopathic complications of diabetes mellitus].
Szénási P, Tóth L, Kammerer L, Romics L.
Orv Hetil. 1989 Mar 19;130(12):617-20. Review. Hungarian.

[Basic principles of drug therapy of hyperlipoproteinemia].
Romics L.
Orv Hetil. 1988 Nov 6;129(45):2391-9. Review. Hungarian. No abstract available.

[The effect of lipanthyl therapy on hyperlipoproteinemia type II/a, II/b and IV].
Karádi I, Pados G, Németh-Csóka M, Romics L.
Orv Hetil. 1988 Aug 14;129(33):1757-60. Hungarian. No abstract available.

[Immunologic correlations of Lp(a) lipoprotein and plasminogen].
Karádi I, Romics L, Gries A, Malle E, Kostner GM.
Orv Hetil. 1988 Jul 3;129(27):1417-20. Hungarian. No abstract available.

The effects of probucol on QT/QS2 relation and systolic time intervals.
Romics L, Littmann L, László Z, Fenyvesi T.
Int J Cardiol. 1988 Jun;19(3):303-8.

Lipoprotein (a) and plasminogen are immunochemically related.
Karadi I, Kostner GM, Gries A, Nimpf J, Romics L, Malle E.
Biochim Biophys Acta. 1988 May 2;960(1):91-7.

Sex- and age-dependence of platelet aggregation in diabetes mellitus.
Szénási P, Tóth L, Romics L, Kammerer L.
Acta Med Hung. 1988;45(1):115-25.

Platelet hyper- and hypoaggregability in different microangiopathic complications of diabetes mellitus.
Szénási P, Tóth L, Romics L, Kammerer L.
Acta Diabetol Lat. 1988 Jan-Mar;25(1):7-12.

HDL protection against atherogenic LDL?
Karádi I, Romics L, Kempler P, Balogh I, Szilvási I, Littmann L.
Basic Res Cardiol. 1987 Nov-Dec;82(6):596-7. No abstract available.

Effect of growth hormone on serum lipoproteins in growth hormone deficiency.
Gács G, Romics L.
Exp Clin Endocrinol. 1987 Sep;90(2):227-31.

[Experience with the determination of antibodies against islet cells].
Pánczél P, Illyés G, Merétey K, Falus A, Romics L.
Orv Hetil. 1986 Nov 2;127(44):2677-80. Hungarian. No abstract available.

[Comparative immunologic study of diabetes mellitus type I and rheumatoid arthritis].
Pánczél P, Illyés G, Merétey K, Falus A, Gyódi E, Romics L, Vértes P, Böhm U.
Orv Hetil. 1986 Oct 12;127(41):2489-95. Hungarian. No abstract available.

[Effect of bezafibrate therapy on serum and lipoprotein lipids].
Romics L, Németh Csóka M, Szám I, Pados G, Karádi I, Köszegi G, Kusztos R.
Orv Hetil. 1986 Oct 5;127(40):2425-8, 2431. Hungarian. No abstract available.

[The importance of the analysis of serum bile acids in chronic liver diseases].
Ungár P, Orbán E, Bély M, Kocsár L, Romics L.
Orv Hetil. 1986 Mar 30;127(13):755-9. Hungarian. No abstract available.

[The Nobel prize for medicine in 1985].
Romics L.
Orv Hetil. 1986 Mar 23;127(12):717-8. Hungarian. No abstract available.

[Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis].
Pánczél P, Falus A, Merétey K, Romics L, Gyódi E, Vértes P, Böhm U, Petrányi G.
Orv Hetil. 1985 May 26;126(21):1281-4, 1287-9. Hungarian. No abstract available.

[Changes in the permeability of the vascular wall in hyperlipoproteinemia and diabetes mellitus].
Romics L, Karádi I, Szilvási I, Kusztos R.
Orv Hetil. 1985 Jan 27;126(4):193-6. Hungarian. No abstract available.

Screening of children with high familial risk of arteriosclerosis.
Szamosi T, Keltai M, Romics L, Németh A.
Acta Paediatr Hung. 1985;26(3):187-91.

[Changes in serum lipids and lipoprotein lipids detected by coronary angiography in ischemic heart disease].
Romics L, Keltai M, Palik I.
Orv Hetil. 1984 Feb 19;125(8):443-8. Hungarian. No abstract available.

[Cholesterol elimination in the urinary tract].
Romics I, Romics L, Szollár L, Tresch J, Szilvási I.
Urologe A. 1983 Sep;22(5):260-1. German.

Serum lipids during starvation in obesity.
Balázsi I, Karádi I, Somogyi A, Jóna G, Romics L.
Acta Med Hung. 1983;40(2-3):133-8.

Drug treatment of hyperlipoproteinaemia.
Romics L.
Ther Hung. 1983;31(4):152-60. Review. No abstract available.

Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
Romics L, Karádi I, Rozenberczki M, Kammerer L.
Acta Med Acad Sci Hung. 1982;39(3-4):117-23.

Hypertriglyceridemia associated with thrombocytopenia and lipoprotein lipase deficiency.
Romics L.
Ann Intern Med. 1981 Nov;95(5):660-1. No abstract available.

[The effect of the correction of carbohydrate metabolism on serum lipids and lipoproteins in insulin-dependent diabetics].
Romics L, Karádi I, Rozenberczki M, Kammerer L.
Orv Hetil. 1980 Dec 21;121(51):3113-6. Hungarian. No abstract available.

[Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
Romics L, Karádi I, Simonyi E.
Orv Hetil. 1980 Oct 26;121(43):2629-31. Hungarian. No abstract available.

[Effect of clofibrate therapy on serum lipids and lipoproteins].
Romics L, Szondy E, Gerö S.
Orv Hetil. 1980 Feb 10;121(6):321-3. Hungarian. No abstract available.

[Structural variations of VLDV triglycerides in some cases of primary observed hyperlipoproteinemias].
Szollár L, Romics L, Pucsok J.
Orv Hetil. 1980 Jan 6;121(1):11-7. Hungarian. No abstract available.

[Lipid metabolism disorders in kidney failure].
Romics L, Makó J.
Orv Hetil. 1978 Dec 10;119(50):3055-8. Hungarian. No abstract available.

[Roentgen anatomy of and serum lipids in the coronary vessels in ischemic heart disease].
Romics L, Keltai M, Palik I, Varsányi-Nagy M.
Orv Hetil. 1978 Apr 9;119(15):895-7. Hungarian. No abstract available.

Abnormal fat metabolism in chronic renal failure.
Romics L, Makó J.
Acta Med Acad Sci Hung. 1978;35(3-4):233-40.

[Serum glycoprotein determination in liver disease].
Fehér J, Jakab L, Lengyel G, Romics L.
Orv Hetil. 1977 Oct 23;118(43):2579-81. Hungarian. No abstract available.

[Serum lipids and lipoproteins in chronic liver diseases].
Fehér J, Romics L, Jakab L, Fehér E, Szilvási I, Papp G.
Orv Hetil. 1977 Jan 23;118(4):194-9. Hungarian. No abstract available.

Effects of different serum components on the cultured endothelial and smooth muscle cells.
Csonka E, Romics L.
Prog Biochem Pharmacol. 1977;13:15-8. No abstract available.

Early retinal vascular signs in hyperlipoproteinaemia.
Romics L, Brooser G.
Acta Med Acad Sci Hung. 1977;34(3):147-54.

[Letter: Value of the Harlan nomogram].
Romics L.
Orv Hetil. 1976 Aug 15;117(33):2033. Hungarian. No abstract available.

[The incidence of ischemic vascular diseases in primary hyperlipoproteinemia (study of 218 patients)].
Romics L, Szigeti A, Varsányi-Nagy M, Gerö S.
Orv Hetil. 1976 Mar 23;117(21):1274-6. Hungarian. No abstract available.

Carbohydrate metabolism in various types of hyperlipoproteinaemia.
Romics L, Stützel M, Balázsi I, Varsányi-Nagy M.
Acta Med Acad Sci Hung. 1976;33(3):225-32.

Serum lipids and lipoproteins in chronic liver disease.
Fehér J, Romics L, Jakab L, Fehér E, Szilvási I, Papp G.
Acta Med Acad Sci Hung. 1976;33(3):217-23.

[Clinical observations on 218 cases of primary hyperlipoproteinemia].
Romics L, Szigeti A, Varsányi-Nagy M, Gerö S.
Orv Hetil. 1975 Oct 26;116(43):2527-31. Hungarian. No abstract available.

Effect of methandrostenolone on serum triglyceride and cholesterol levels in diabetic patients.
Romics L, Bretán M, Szigeti A, Varsányi-Nagy M.
Acta Med Acad Sci Hung. 1975;32(1):27-34.

Effect of insulin on plasma postheparin lipoprotein lipase activity in patients with coronary sclerosis and in control subjects.
Orosz L, Erdélyi G, Romics L, Gerö S.

[Determination of the blood volume circulating through the muscle tissue].
Lelkes J, Molnár G, Romics L.
Orv Hetil. 1973 Jul 29;114(30):1835-6. Hungarian. No abstract available.

[Measuring muscular blood flow with Xenon- 133 ].
Molnár G, Romics L.
Orv Hetil. 1972 Oct 15;113(42):2537-8. Hungarian. No abstract available.

[Insulin level of blood in coronary sclerosis and obesity].
Balázsi I, Stützel M, Varsányi-Nagy M, Romics L, Szigeti A.
Orv Hetil. 1972 Apr 23;113(17):986-9. Hungarian. No abstract available.

[Plasma insulin in coronary arteriosclerosis and obesity].
Balazsi I, Stützel M, Varsányi-Nagy M, Romics L, Szigeti A.
Z Gesamte Inn Med. 1972 Feb 1;27(3):116-9. German. No abstract available.

[Determination of glomerular clearance with radioactive metal complexes without urine analysis].
Molnár G, Pál I, Romics L, Fejéregyházi I.
Orv Hetil. 1970 Jan 25;111(4):199-203. Hungarian. No abstract available.

Measurement of glomerular filtration-rate.
Molnár GY, Romics L, Fejéregyházi I, Pál A.
Lancet. 1969 Feb 1;1(7588):261. No abstract available.

[The role of gastric juice mucopolysaccharides in the formation of the blood lipid picture. 1. Correlation between the gastric juice and serum mucopolysaccharide content and blood lipid values in healthy subjects].
Gerö S, Bihari-Varga M, Székely J, Romics L, Steingaszner O.
Orv Hetil. 1965 Sep 19;106(38):1780-3. Hungarian. No abstract available.

The role of the adrenal gland in the development of Shay-ulcer in the rat.
SELMECI L, ROMICS L.
Acta Physiol Acad Sci Hung. 1962;22:89-91. No abstract available.

[On the inhibitory effect of intraduodenally administered olive oil on the development of Shay's ulcer in rats].
GATI T, GELENCSER F, PALIK I, ROMICS L, LABANT M.
Dtsch Z Verdau Stoffwechselkr. 1961 Sep;21:152-6. German. No abstract available.